J&J Shares Rise on Strong Earnings, Optimistic Outlook, and Cost Savings
Johnson & Johnson's stock surged after raising its 2025 guidance following a strong Q2 report, which also positively impacts the outlook for other medtech companies like Stryker, Medtronic, and Boston Scientific due to broad industry growth and specific segment performances.